The company's lead PEC - DirectTM product candidate is entering clinical development as a potential functional
cure for patients with type 1 diabetes with the highest risk of life threatening acute complications.
After implantation, the cells are expected to mature into the full complement of islet cells, including insulin - producing beta cells, offering a potential functional
cure for patients with high - risk type 1 diabetes.
In addition, we believe that success with PEC - Direct is an important step on the path to a functional
cure for all patients with type 1 diabetes, helping to fulfill our commitment of turning Type One into Type None.»
To deliver a functional
cure for all patients with type 1 diabetes and an important new therapy for patients with type 2 disease that require insulin to maintain control, ViaCyte is developing products with numerous advantages including a virtually unlimited supply of cells manufactured under quality - controlled conditions, and a potentially safer and more optimal route of administration.
The funding will help support our current clinical trial evaluating the safety and efficacy of ViaCyte's PEC - Direct product candidate, which is in development as a potential
cure for patients with high - risk type 1 diabetes.
«Of course, there are many years of additional studies that are required first, but this study provides hope for
a cure for all patients with diabetes,» said John Buse, M.D., Ph.D., president of the American Diabetes Association and professor and chief of the endocrinology division in the UNC School of Medicine's department of medicine.
Used with concomitant maintenance immune suppression therapy, the PEC - Direct product has the potential of delivering a sustained, functional
cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.
While PEC - Direct development could advance more rapidly and make a major impact for the subset of type 1 diabetes patients at highest risk, we view PEC - EnCap as holding the promise of a functional
cure for all patients with type 1 diabetes as well as an important therapy for many patients with type 2 diabetes.»
We remain fully committed to developing a functional
cure for all patients with insulin - requiring diabetes.
San Diego, August 1, 2017 — ViaCyte, Inc., a privately - held, leading regenerative medicine company, announced today that the first patients have been implanted with the PEC - Direct ™ product candidate, a novel islet cell replacement therapy in development as a functional
cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.
Not exact matches
While the new mid-stage study results from DNDi were impressive (they showed
cure rates of 96 % to 97 % even
for the sickest
patients and those
with liver scarring), more late - stage trials will be necessary before the drug is available on a large scale in the developing world.
«The goal is to provide an all - oral, once daily, safe and tolerable regimen
with a high
cure rate
for as little as eight to 12 weeks
for all
patients,» Sonnier said.
One particularly sad story was entitled «Maimed on 9/11, Trying to Be Whole Again,» while an article
with the headline «Rare Treatment is Reported to
Cure AIDS
Patient» scored high
for awe.
This might provide some insight as to why news editors are killing stories about
curing cancer
with cannabis, and why the government is still handing out lifetime jail sentences to dispensary owners
for selling the possible
cure to cancer to sick and dying
patients.
We have had
cures for Cancer
for 60 years, strangely, they are «debunked» by the medical establishment as quackery so they can poison each cancer
patient with over priced pharmaceuticals.
When faced,
for example,
with the decision of whether or not to let a seriously ill or irreversible
patient succumb voluntarily in terminal situations, we might avoid making the decision now, arguing
for the possibility — maybe next week — that a new
cure for the
patient's condition will be discovered.
I have a bachelor degree in social studies and worked
for many years
with people at group homes in Denmark and experienced everyday how focused the doctors were on trying to
cure the
patients with drugs.
For fourteen to eighteen days,
patients are fed the chiles, beginning
with one the first day, two the second day, and so on until they are
cured.
Diabetes books how you get type 1 diabetes how to
cure diabetes naturally
with natural food, how to reverse diabetes permanently tasty recipes
for diabetes
patients.
For every 11
patients with H. pylori who are treated
with antibiotics, 10 are
cured of their peptic ulcer.
For example, a consortium of research groups called the London Project to
Cure Blindness aims to test RPE transplants from embryonic stem cells in
patients with macular degeneration this year.
Inflicting less collateral damage to surrounding organs and healthy tissues, it can minimize side effects and increase
cure rates
for some cancers — just what
patients with small bodies like Jonathan need.
As treatments
for HCV have evolved, genotype 3
patients have become the most difficult subgroup of
patients to
cure.1 Although there have been recent advances in direct - acting antiviral therapies
for HCV genotype 1, genotype 3 remains a challenge and is a highly prevalent strain of the infection globally,
with a particularly high concentration of cases in Asia.1
For young AML
patients with suitable bone marrow donors, transplantation offers the best chance of a
cure.
And although they may represent only another small step toward a «
cure»
for diabetes, they are beginning to provide
patients with levels of control never before seen over their own hormones.
«In addition to creating new beta cells, another issue that needs to be addressed to achieve a
cure for type 1 diabetes is that any new beta cells will be attacked by the autoimmune response present in every
patient with type 1 diabetes.
Ocrevus isn't a
cure, and it offers no relief
for 30 to 40 percent of
patients with primary progressive MS. Davis was in that disappointed group.
A new drug is offering dramatic
cure rates
for hepatitis C
patients with two subtypes of the infection — genotype 2 and 3, say a team of scientists led by Weill Cornell Medical College researchers.
Cure rates were very high even
for the hardest - to - treat
patients: people
with liver cirrhosis (96 %
cured), people living
with HIV using their usual treatment (97 %), people infected
with genotype 3 (97 %) including those
with cirrhosis (96 %), and people who had been exposed to previous HCV treatments (96 %).
An affordable hepatitis C combination treatment including the new drug candidate ravidasvir has been shown to be safe and effective,
with extremely high
cure rates
for patients, including hard - to - treat cases, according to interim results from the Phase II / III STORM - C - 1 trial presented by the non-profit research and development organisation Drugs
for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris.
Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)- infected cells in the blood samples of
patients treated
with antiretroviral therapy, offering the promise of a strategy
for curing HIV infection.
«We're at a pivotal point where we're building upon what we've learned in the PLAT - 02 trial and opening new trials, like PLAT - 04,
with the goal of improving this therapy to the point that it becomes a long - term
cure for all of our leukemia
patients,» said Dr. Corinne Summers, an oncologist at Seattle Children's and the lead investigator of the PLAT - 04 trial.
However, around that time my Mum was diagnosed
with multiple sclerosis, and I became very interested in learning more about this disease and ways to treat it.In January 2002 I decided, after much thought, that I should change direction and study neuroscience, as the best thing I could do
for MS
patients is to work on a
cure.
For most of the solid tumors that we work
with, unfortunately, once the cancer has spread to a distant place, we're at this point unable to
cure those
patients, although we can oftentimes improve their quality of life or make them live longer.
Current treatments include transplanting
patients with donor HSC, which is a potential
cure for SCD, but due to the serious risks of rejection, only a small number of
patients have undergone this procedure and it is usually restricted to children
with severe symptoms.
While direct - acting antivirals have been used to treat and
cure adult
patients with HCV, until now children have been mainly treated
for 24 to 48 weeks
with pegylated interferon plus ribavirin (RBV), an older treatment which causes severe side effects.
But as recently as the early 20th century, intentional infection was seen as cutting - edge: Austrian psychiatrist Julius Wagner - Jauregg won the 1927 Nobel Prize in Physiology or Medicine
for injecting blood from people
with malaria into
patients with neurosyphilis, which putatively
cured them of insanity and paralysis.
The first international
patient registry has been launched
for primary ciliary dyskinesia (PCD)-- a rare lung disease causing long - term and recurring respiratory infections,
with no approved treatments and no
cure.
Scientists report in the May 9 Science Translational Medicine that seven of 12 diabetic mice treated
with this combination were
cured even after having lost the ability to make insulin
for several weeks, the equivalent of a human
patient who has needed insulin injections
for a couple of years.
In 2013 the Centers
for Medicare & Medicaid Services (CMS) declined to cover the tests, citing insufficient evidence that they would make a difference
for patients with a disease
for which there is no
cure and limited treatment available.
In addition to funding innovative research like the Catalyst
for a
Cure consortium and Shaffer Grants, Glaucoma Research Foundation provides free educational material including the definitive reference
for newly diagnosed
patients, «Understanding and Living
with Glaucoma,» brochures serving those at highest risk including African Americans and Latinos, and a comprehensive website www.glaucoma.org that answers
patients» questions about glaucoma.
«Working closely alongside the drug development teams at Merck offers an outstanding opportunity to create new benchmarks
for the R&D process,
with the ultimate goal of optimizing drug candidates earlier by testing them in Organ - Chips that mirror what happens in the
patients whom the medicines are designed to treat and
cure,» said Geraldine A. Hamilton, Ph.D., President and Chief Scientific Officer of Emulate.
For patients with breast cancer this may be used after breast surgery to treat the surrounding breast and / or regional tissues to increase the chance of
cure.
Sonia Vallabh and Eric Minikel —
Patient with fatal familia insomnia and her spouse, who have redirected their lives find a
cure for her disorder
A recent study shows that cytokines are elevated in
patients with severe chronic fatigue syndrome, potentially paving the way
for a more definitive test and
cure.
Cure rates are higher
for patients with lower stages (stages 1 - 3) of disease.
Your help makes it possible to meet
patients» needs, hold impactful conferences, develop fresh education programs and fund research
for the
cures, along
with improved treatments until
cures are discovered.
Armed
with knowledge of which mistakes in genes are driving which cancers, doctors and scientists will be able to maximise the chances of
cure for each
patient by picking the best treatments and by developing new and more targeted treatments
for people
with oesophageal and prostate cancers in the future.
Together
with Nephcure Kidney International and Levine Children's Hospital, U-M administers the NephCure Accelerating
Cures Institute (NACI)-- a partnership designed to accelerate the development of safe and effective therapies
for patients with nephrotic syndrome.
Medical experts along
with patients who have been treated
with immunotherapy will discuss how research and
patient participation in clinical trials is helping us get closer to
cures for all types of cancer.